tert-Butyl 4-oxopiperidine-1-carboxylate → 1,1-dimethylethyl 4-[7-(aminocarbonyl)-5-bromo-1H-indol-3-yl]-3,6-dihydro-1(2H)-pyridinecarboxylate

HRID 562012Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 562012
[Br:1][C:2]1[CH:3]=[C:4]2[C:8](=[C:9]([C:11]([NH2:13])=[O:12])[CH:10]=1)[NH:7][CH:6]=[CH:5]2.O=[C:15]1[CH2:20][CH2:19][N:18]([C:21]([O:23][C:24]([CH3:27])([CH3:26])[CH3:25])=[O:22])[CH2:17][CH2:16]1.C[O-].[Na+]>CO>[NH2:13][C:11]([C:9]1[CH:10]=[C:2]([Br:1])[CH:3]=[C:4]2[C:8]=1[NH:7][CH:6]=[C:5]2[C:15]1[CH2:20][CH2:19][N:18]([C:21]([O:23][C:24]([CH3:27])([CH3:26])[CH3:25])=[O:22])[CH2:17][CH:16]=1)=[O:12]

Komponenten

5

Versuchsvorschrift

To a solution of 5-bromo-1H-indole-7-carboxamide (10 g, 41.84 mmol) in methanol (5 mL), 1,1-dimethylethyl 4-oxo-1-piperidinecarboxylate (684 mg, 3.42 mmol) and sodium methoxide (0.5 M in THF, 13.7 mL, 6.84 mmol) were added. The reaction mixture was stirred at reflux temperature for 16 hours. All solvent was evaporated under reduced pressure. The residue was partitioned between ethyl acetate (100 mL) and water (100 mL). The combined organic phase was dried over MgSO4 and concentrated under reduced pressure, and purified by flash column chromatography (ethyl acetate/hexanes, 1/1) to give the desired product (7.4 g, 43

Aufarbeitung

  1. temperatureat reflux temperature for 16 hours
  2. customAll solvent was evaporated under reduced pressure
  3. customThe residue was partitioned between ethyl acetate (100 mL) and water (100 mL)
  4. dry with materialThe combined organic phase was dried over MgSO4
  5. concentrationconcentrated under reduced pressure
  6. custompurified by flash column chromatography (ethyl acetate/hexanes, 1/1)

Quellen und Nachweise

ORD-Eintrag
ord-dabc5e7f1d5440eb9819dfd7341f5a5b
Quelldatensatz
uspto-grants-2011_11
Patentnummer
US08063071B2

Notizen zur Reaktion

Wird geladen…